Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantinos Tsatalas

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Blood|June 20, 2015
Plerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapyGaryfalia Karponi, Nikoletta Psatha, Carsten Werner Lederer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Primary treatment of Waldenström macroglobulinemia with dexamethasone, rituximab, and cyclophosphamideMeletios Athanasios Dimopoulos, Athanasios Anagnostopoulos, Marie-Christine Kyrtsonis, et al.
European Journal of Haematology|April 4, 2012
Multiple myeloma in octogenarians: clinical features and outcome in the novel agent eraMeletios A Dimopoulos, Efstathios Kastritis, Sossana Delimpasi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2015
The Stat3/5 Signaling Biosignature in Hematopoietic Stem/Progenitor Cells Predicts Response and Outcome in Myelodysplastic Syndrome Patients Treated with AzacitidineParaskevi Miltiades, Eleftheria Lamprianidou, Theodoros P Vassilakopoulos, et al.
Leukemia Research|May 8, 2010
Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH)Efstathios Kastritis, Marie-Christine Kyrtsonis, Evdoxia Hadjiharissi, et al.
Haematologica|January 26, 2006
Pure infradiaphragmatic Hodgkin's lymphoma. Clinical features, prognostic factor and comparison with supradiaphragmatic diseaseTheodoros P Vassilakopoulos, Maria K Angelopoulou, Marina P Siakantaris, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Blood|June 20, 2015
Plerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapyGaryfalia Karponi, Nikoletta Psatha, Carsten Werner Lederer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Primary treatment of Waldenström macroglobulinemia with dexamethasone, rituximab, and cyclophosphamideMeletios Athanasios Dimopoulos, Athanasios Anagnostopoulos, Marie-Christine Kyrtsonis, et al.
European Journal of Haematology|April 4, 2012
Multiple myeloma in octogenarians: clinical features and outcome in the novel agent eraMeletios A Dimopoulos, Efstathios Kastritis, Sossana Delimpasi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2015
The Stat3/5 Signaling Biosignature in Hematopoietic Stem/Progenitor Cells Predicts Response and Outcome in Myelodysplastic Syndrome Patients Treated with AzacitidineParaskevi Miltiades, Eleftheria Lamprianidou, Theodoros P Vassilakopoulos, et al.
Leukemia Research|May 8, 2010
Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH)Efstathios Kastritis, Marie-Christine Kyrtsonis, Evdoxia Hadjiharissi, et al.
Haematologica|January 26, 2006
Pure infradiaphragmatic Hodgkin's lymphoma. Clinical features, prognostic factor and comparison with supradiaphragmatic diseaseTheodoros P Vassilakopoulos, Maria K Angelopoulou, Marina P Siakantaris, et al.
Pageof 2